Article

Quantinuum introduces its Generative Quantum AI framework, leveraging quantum-generated data for commercial applications in drug discovery, financial modeling, and logistics. The framework enhances AI systems using data from the System Model H2 quantum computer, aiming to improve medical development and supply chain efficiency.

Collaborative initiatives are underway with various industries, including automotive and pharmaceuticals. The Helios system, expected by mid-2025, will further enhance drug discovery capabilities. This development follows a partnership expansion with SoftBank.